Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Top Cited Papers
- 29 May 2009
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 76 (2), 215-228
- https://doi.org/10.1124/mol.109.056705
Abstract
Sex differences in pharmacokinetics and pharmacodynamics characterize many drugs and contribute to individual differences in drug efficacy and toxicity. Sex-based differences in drug metabolism are the primary cause of sex-dependent pharmacokinetics and reflect underlying sex differences in the expression of hepatic enzymes active in the metabolism of drugs, steroids, fatty acids and environmental chemicals, including cytochromes P450 (P450s), sulfotransferases, glutathione transferases, and UDP-glucuronosyltransferases. Studies in the rat and mouse liver models have identified more than 1000 genes whose expression is sex-dependent; together, these genes impart substantial sexual dimorphism to liver metabolic function and pathophysiology. Sex differences in drug metabolism and pharmacokinetics also occur in humans and are due in part to the female-predominant expression of CYP3A4, the most important P450 catalyst of drug metabolism in human liver. The sexually dimorphic expression of P450s and other liver-expressed genes is regulated by the temporal pattern of plasma growth hormone (GH) release by the pituitary gland, which shows significant sex differences. These differences are most pronounced in rats and mice, where plasma GH profiles are highly pulsatile (intermittent) in male animals versus more frequent (nearly continuous) in female animals. This review discusses key features of the cell signaling and molecular regulatory mechanisms by which these sex-dependent plasma GH patterns impart sex specificity to the liver. Moreover, the essential role proposed for the GH-activated transcription factor signal transducer and activator of transcription (STAT) 5b, and for hepatic nuclear factor (HNF) 4α, as mediators of the sex-dependent effects of GH on the liver, is evaluated. Together, these studies of the cellular, molecular, and gene regulatory mechanisms that underlie sex-based differences in liver gene expression have provided novel insights into the physiological regulation of both xenobiotic and endobiotic metabolism.Keywords
This publication has 217 references indexed in Scilit:
- Hormonal Regulation of Hepatic Drug-Metabolizing Enzyme Activity During AdolescenceClinical Pharmacology & Therapeutics, 2008
- Age- and sex-dependent expression of multiple murine hepatic hydroxysteroid sulfotransferase (SULT2A) genesBiochemical Pharmacology, 2008
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific TranscriptionCell, 2008
- Tissue-specific transcriptional regulation has diverged significantly between human and mouseNature Genetics, 2007
- Direct glucocorticoid receptor–Stat5 interaction in hepatocytes controls body size and maturation-related gene expressionGenes & Development, 2007
- Multiple mechanisms of growth hormone-regulated gene transcriptionMolecular Genetics and Metabolism, 2007
- The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expressionPharmacology & Therapeutics, 2007
- CAR and PXR: The xenobiotic-sensing receptors☆Steroids, 2006
- Tissue-specific expression and regulation of sexually dimorphic genes in miceGenome Research, 2006
- Signalling cross-talk between hepatocyte nuclear factor 4α and growth-hormone-activated STAT5bBiochemical Journal, 2006